considered curative treatments for hepatocellular carcinoma (HCC), but their economic
impact still remains not determined. Aim of the present study was to analyze the cost-
effectiveness (CE) of these two strategies in early stage HCC (Milan criteria). Methods As
first step, a meta-analysis of the pertinent literature of the last decade was performed.
Seventeen studies fulfilled the inclusion criteria: 3996 patients underwent resection and …